|
[1]
|
Gao, C., Sun, X., Lu, L., Liu, F. and Yuan, J. (2018) Prevalence of Gestational Diabetes Mellitus in Mainland China: A Systematic Review and Meta‐Analysis. Journal of Diabetes Investigation, 10, 154-162. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Ye, W., Luo, C., Huang, J., Li, C., Liu, Z. and Liu, F. (2022) Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes: Systematic Review and Meta-Analysis. BMJ, 377, e067946. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wang, Y., Wu, H., Ding, H., Li, Y., Wang, Z., Li, F., et al. (2012) Changes of Insulin Resistance and β‐Cell Function in Women with Gestational Diabetes Mellitus and Normal Pregnant Women during Mid‐ and Late Pregnant Period: A Case-Control Study. Journal of Obstetrics and Gynaecology Research, 39, 647-652. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Fasshauer, M. and Blüher, M. (2015) Adipokines in Health and Disease. Trends in Pharmacological Sciences, 36, 461-470. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M., et al. (1998) Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor. Biochemical and Biophysical Research Communications, 251, 471-476. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lee, D.K., Cheng, R., Nguyen, T., Fan, T., Kariyawasam, A.P., Liu, Y., et al. (2000) Characterization of Apelin, the Ligand for the APJ Receptor. Journal of Neurochemistry, 74, 34-41. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Carpéné, C., Dray, C., Attané, C., Valet, P., Portillo, M.P., Churruca, I., et al. (2007) Expanding Role for the Apelin/APJ System in Physiopathology. Journal of Physiology and Biochemistry, 63, 358-373. [Google Scholar] [CrossRef]
|
|
[8]
|
Malchow, J., Eberlein, J., Li, W., Hogan, B.M., Okuda, K.S. and Helker, C.S.M. (2024) Neural Progenitor-Derived Apelin Controls Tip Cell Behavior and Vascular Patterning. Science Advances, 10, eadk1174. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Fasshauer, M., Blüher, M. and Stumvoll, M. (2014) Adipokines in Gestational Diabetes. The Lancet Diabetes & Endocrinology, 2, 488-499. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Higuchi, K., Masaki, T., Gotoh, K., Chiba, S., Katsuragi, I., Tanaka, K., et al. (2007) Apelin, an APJ Receptor Ligand, Regulates Body Adiposity and Favors the Messenger Ribonucleic Acid Expression of Uncoupling Proteins in Mice. Endocrinology, 148, 2690-2697. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Yue, P., Jin, H., Xu, S., Aillaud, M., Deng, A.C., Azuma, J., et al. (2011) Apelin Decreases Lipolysis via Gq, Gi, and AMPK-Dependent Mechanisms. Endocrinology, 152, 59-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
El Wakeel, M.A., El-Kassas, G.M., Kamhawy, A.H., Galal, E.M., Nassar, M.S., Hammad, E.M., et al. (2018) Serum Apelin and Obesity-Related Complications in Egyptian Children. Open Access Macedonian Journal of Medical Sciences, 6, 1354-1358. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Yalçın, T., Oğuz, S.H., Bayraktar, M. and Rakıcıoğlu, N. (2021) Anthropometric Measurements and Serum TNF-α, IL-6 and Adiponectin in Type 2 Diabetes. Diabetology International, 13, 396-406. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zhao, X., Niu, Y., Zhao, X., Ruan, H., Xiang, Y., Wang, L., et al. (2023) Associations between Serum TNF-α, IL-6, hs-CRP and GLMD in Obese Children and Adolescents: A Cross-Sectional Study. Diabetes, Metabolic Syndrome and Obesity, 16, 3915-3923. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Yu, S., Zhang, Y., Li, M.Z., et al. (2012) Chemerin and Apelin Are Positively Correlated with Inflammation in Obese Type 2 Diabetic Patients. Chinese Medical Journal, 125, 3440-3444.
|
|
[16]
|
Peng, Q., Zhou, J., Xu, Z., Zhao, Q., Li, Z. and Zhao, Q. (2022) Apelin-13 Ameliorates LPS-Induced BV-2 Microglia Inflammatory Response through Promoting Autophagy and Inhibiting H3K9ac Enrichment of TNF-α and IL-6 Promoter. Acta Neurobiologiae Experimentalis, 82, 65-76. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Wei, Y.F., Yin, P., Liu, L., et al. (2019) Effects of APELIN-13 on the Expression of IL-6, TNF-α, and IFN-γ in Rats with Experimental Autoimmune Neuritis. Journal of Biological Regulators and Homeostatic Agents, 33, 1369-1376.
|
|
[18]
|
Castan-Laurell, I., El Boustany, R., Pereira, O., Potier, L., Marre, M., Fumeron, F., et al. (2019) Plasma Apelin and Risk of Type 2 Diabetes in a Cohort from the Community. Diabetes Care, 43, e15-e16. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Noori-Zadeh, A., Bakhtiyari, S., Khanjari, S., Haghani, K. and Darabi, S. (2019) Elevated Blood Apelin Levels in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Research and Clinical Practice, 148, 43-53. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Mund, C., Kellellu, C.K., Rattan, R., Mahapatra, S., Lamare, A.A. and Jena, S. (2023) Study of Serum Apelin and Insulin Resistance in Type 2 Diabetes Mellitus Patients with or without Obesity. Cureus, 15, e43401. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
McIntyre, H.D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E.R. and Damm, P. (2019) Gestational Diabetes Mellitus. Nature Reviews Disease Primers, 5, Article No. 47. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Alwash, S.M., McIntyre, H.D. and Mamun, A. (2021) The Association of General Obesity, Central Obesity and Visceral Body Fat with the Risk of Gestational Diabetes Mellitus: Evidence from a Systematic Review and Meta-Analysis. Obesity Research & Clinical Practice, 15, 425-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Pérez-López, F.R., Wu, J., Yao, L., López-Baena, M.T., Pérez-Roncero, G.R. and Varikasuvu, S.R. (2022) Apelin Levels in Pregnant Women with and without Gestational Diabetes Mellitus: A Collaborative Systematic Review and Meta-Analysis. Gynecological Endocrinology, 38, 803-812. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
de Mendonça, E.L.S.S., Fragoso, M.B.T., de Oliveira, J.M., Xavier, J.A., Goulart, M.O.F. and de Oliveira, A.C.M. (2022) Gestational Diabetes Mellitus: The Crosslink among Inflammation, Nitroxidative Stress, Intestinal Microbiota and Alternative Therapies. Antioxidants, 11, Article 129. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Li, Y., Long, D., Liu, J., Qiu, D., Wang, J., Cheng, X., et al. (2020) Gestational Diabetes Mellitus in Women Increased the Risk of Neonatal Infection via Inflammation and Autophagy in the Placenta. Medicine, 99, e22152. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Arani Hessari, F., Sharifi, M., Yousefifard, M., Gholamzadeh, R., Nazarinia, D. and Aboutaleb, N. (2022) Apelin-13 Attenuates Cerebral Ischemia/Reperfusion Injury through Regulating Inflammation and Targeting the JAK2/STAT3 Signaling Pathway. Journal of Chemical Neuroanatomy, 126, Article 102171. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
He, X., Liu, C., Peng, J., Li, Z., Li, F., Wang, J., et al. (2021) COVID-19 Induces New-Onset Insulin Resistance and Lipid Metabolic Dysregulation via Regulation of Secreted Metabolic Factors. Signal Transduction and Targeted Therapy, 6, Article No. 427. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Attané, C., Foussal, C., Le Gonidec, S., Benani, A., Daviaud, D., Wanecq, E., et al. (2012) Apelin Treatment Increases Complete Fatty Acid Oxidation, Mitochondrial Oxidative Capacity, and Biogenesis in Muscle of Insulin-Resistant Mice. Diabetes, 61, 310-320. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Bertrand, C., Pradère, J., Geoffre, N., Deleruyelle, S., Masri, B., Personnaz, J., et al. (2018) Chronic Apelin Treatment Improves Hepatic Lipid Metabolism in Obese and Insulin-Resistant Mice by an Indirect Mechanism. Endocrine, 60, 112-121. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Dray, C., Knauf, C., Daviaud, D., Waget, A., Boucher, J., Buléon, M., et al. (2008) Apelin Stimulates Glucose Utilization in Normal and Obese Insulin-Resistant Mice. Cell Metabolism, 8, 437-445. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Guo, Y., Li, T., Liu, H., Tang, L., Li, Y., Hu, H., et al. (2020) Circulating Levels of Elabela and Apelin in the Second and Third Trimesters of Pregnancies with Gestational Diabetes Mellitus. Gynecological Endocrinology, 36, 890-894. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
孔玉玲, 石国素, 刘慧丽, 等. 妊娠期糖尿病孕妇血清脂肪因子Apelin水平与糖脂代谢相关性[J]. 中国计划生育学杂志, 2021, 29(12): 2650-2654.
|
|
[33]
|
杨金霞, 李玮芳, 马登琴, 等. 妊娠期糖尿病患者空腹血清FGF21、Nesfatin-1及Apelin-36水平变化与胰岛素抵抗和胰岛素细胞功能的相关性分析[J]. 中国妇产科临床杂志, 2023, 24(3): 303-304.
|
|
[34]
|
Oncul, M., Tuten, A., Erman, H., et al. (2013) Maternal and Cord Blood Apelin, Resistin and Visfatin Levels in Gestational Diabetes Mellitus. Minerva Medica, 104, 527-535.
|
|
[35]
|
Aslan, M., Celik, O., Celik, N., Turkcuoglu, I., Yilmaz, E., Karaer, A., et al. (2011) Cord Blood Nesfatin-1 and Apelin-36 Levels in Gestational Diabetes Mellitus. Endocrine, 41, 424-429. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Dessì, A., Pravettoni, C., Cesare Marincola, F., Schirru, A. and Fanos, V. (2015) The Biomarkers of Fetal Growth in Intrauterine Growth Retardation and Large for Gestational Age Cases: From Adipocytokines to a Metabolomic All-in-One Tool. Expert Review of Proteomics, 12, 309-316. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Cekmez, F., Canpolat, F.E., Pirgon, O., Çetinkaya, M., Aydinoz, S., Suleymanoglu, S., et al. (2011) Apelin, Vaspin, Visfatin and Adiponectin in Large for Gestational Age Infants with Insulin Resistance. Cytokine, 56, 387-391. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Mayeur, S., Wattez, J., Lukaszewski, M., Lecoutre, S., Butruille, L., Drougard, A., et al. (2015) Apelin Controls Fetal and Neonatal Glucose Homeostasis and Is Altered by Maternal Undernutrition. Diabetes, 65, 554-560. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Cekmez, F., Pirgon, O., Aydemir, G., Dundar, B., Çekmez, Y., Karaoglu, A., et al. (2012) Correlation between Cord Blood Apelin and IGF-1 Levels in Retinopathy of Prematurity. Biomarkers in Medicine, 6, 821-825. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Hanssens, S., Marousez, L., Pécheux, O., Besengez, C., Storme, L., Deruelle, P., et al. (2022) Maternal Obesity Reduces Apelin Level in Cord Blood without Altering the Placental Apelin/Elabela-APJ System. Placenta, 128, 112-115. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Aydin, S. (2010) The Presence of the Peptides Apelin, Ghrelin and Nesfatin-1 in the Human Breast Milk, and the Lowering of Their Levels in Patients with Gestational Diabetes Mellitus. Peptides, 31, 2236-2240. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Gutaj, P., Sibiak, R., Jankowski, M., Awdi, K., Bryl, R., Mozdziak, P., et al. (2020) The Role of the Adipokines in the Most Common Gestational Complications. International Journal of Molecular Sciences, 21, Article 9408. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Hu, H., He, L., Li, L. and Chen, L. (2016) Apelin/APJ System as a Therapeutic Target in Diabetes and Its Complications. Molecular Genetics and Metabolism, 119, 20-27. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Gao, L.R., Zhang, N.K., Zhang, Y., Chen, Y., Wang, L., Zhu, Y., et al. (2018) Overexpression of Apelin in Wharton’ Jelly Mesenchymal Stem Cell Reverses Insulin Resistance and Promotes Pancreatic β Cell Proliferation in Type 2 Diabetic Rats. Stem Cell Research & Therapy, 9, Article No. 339. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
O’Harte, F.P.M., Parthsarathy, V., Hogg, C. and Flatt, P.R. (2018) Long-Term Treatment with Acylated Analogues of Apelin-13 Amide Ameliorates Diabetes and Improves Lipid Profile of High-Fat Fed Mice. PLOS ONE, 13, e0202350. [Google Scholar] [CrossRef] [PubMed]
|